Erika L. Little
Research Subjects
Research Interests
Erika L. Little has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Anthony P. Pietropaoli
Division of Pulmonary & Critical Care Medicine, University of Rochester Medical Center, Rochester, USA
2 shared publications - David Chalupa
Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
2 shared publications - David Oakes
Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, USA
2 shared publications - Jelani Wiltshire
Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA, and
2 shared publications - Mark J. Utell
Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY, USA; Department of Medicine, Division of Pulmonary and Critical Care, University of Rochester Medical Center, Rochester, NY, USA
2 shared publications - Mark W. Frampton
Department of Medicine
2 shared publications
Latest Publications
- 20 January 2015
- Published by Taylor & Francis in Inhalation Toxicology
- Vol. 27 (2) , 113-119
Cardiovascular effects of ozone in healthy subjects with and without deletion of glutathione-S-transferase M1
Context: Exposure to ozone has acute respiratory effects, but few human clinical studies have evaluated cardiovascular effects. Objective: We hypothesized that ozone exposure alters pulmonary and systemic vascular function, and cardiac function, with more pronounced effects in subjects with impaired antioxidant defense from deletion of the glutathione-S-transferase M1 gene (GSTM1 null). Methods: Twenty-four young, healthy never-smoker subjects (12 GSTM1 null) inhaled filtered air, 100 ppb ozone and 200 ppb ozone for 3 h, with intermittent exercise, in a double-blind, randomized, crossover fashion. Exposures were separated by at least 2 weeks. Vital signs, spirometry, arterial and venous blood nitrite levels, impedance cardiography, peripheral arterial tonometry, estimation of pulmonary capillary blood volume (Vc), and blood microparticles and platelet activation were measured at baseline and during 4 h after each exposure. Results: Ozone inhalation decreased lung function immediately after exposure (mean ± standard error change in FEV1, air: −0.03 ± 0.04 L; 200 ppb ozone: −0.30 ± 0.07 L; p < 0.001). The immediate post-exposure increase in blood pressure, caused by the final 15-min exercise period, was blunted by 200 ppb ozone exposure (mean ± standard error change for air: 16.7 ± 2.6 mmHg; 100 ppb ozone: 14.5 ± 2.4 mmHg; 200 ppb ozone: 8.5 ± 2.5 mmHg; p = 0.02). We found no consistent effects of ozone on any other measure of cardiac or vascular function. All results were independent of the GSTM1 genotype. Conclusions: We did not find convincing evidence for early acute adverse cardiovascular consequences of ozone exposure in young healthy adults. The ozone-associated blunting of the blood pressure response to exercise is of unclear clinical significance.
- 20 January 2015
- Published by Taylor & Francis in Inhalation Toxicology
- Vol. 27 (2) , 113-119
Cardiovascular effects of ozone in healthy subjects with and without deletion of glutathione-S-transferase M1
Context: Exposure to ozone has acute respiratory effects, but few human clinical studies have evaluated cardiovascular effects. Objective: We hypothesized that ozone exposure alters pulmonary and systemic vascular function, and cardiac function, with more pronounced effects in subjects with impaired antioxidant defense from deletion of the glutathione-S-transferase M1 gene (GSTM1 null). Methods: Twenty-four young, healthy never-smoker subjects (12 GSTM1 null) inhaled filtered air, 100 ppb ozone and 200 ppb ozone for 3 h, with intermittent exercise, in a double-blind, randomized, crossover fashion. Exposures were separated by at least 2 weeks. Vital signs, spirometry, arterial and venous blood nitrite levels, impedance cardiography, peripheral arterial tonometry, estimation of pulmonary capillary blood volume (Vc), and blood microparticles and platelet activation were measured at baseline and during 4 h after each exposure. Results: Ozone inhalation decreased lung function immediately after exposure (mean ± standard error change in FEV1, air: −0.03 ± 0.04 L; 200 ppb ozone: −0.30 ± 0.07 L; p < 0.001). The immediate post-exposure increase in blood pressure, caused by the final 15-min exercise period, was blunted by 200 ppb ozone exposure (mean ± standard error change for air: 16.7 ± 2.6 mmHg; 100 ppb ozone: 14.5 ± 2.4 mmHg; 200 ppb ozone: 8.5 ± 2.5 mmHg; p = 0.02). We found no consistent effects of ozone on any other measure of cardiac or vascular function. All results were independent of the GSTM1 genotype. Conclusions: We did not find convincing evidence for early acute adverse cardiovascular consequences of ozone exposure in young healthy adults. The ozone-associated blunting of the blood pressure response to exercise is of unclear clinical significance.
- Open Access
- 16 July 2014
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 11 (1) , 31
Inhalation of ultrafine carbon particles alters heart rate and heart rate variability in people with type 2 diabetes
Diabetes may confer an increased risk for the cardiovascular health effects of particulate air pollution, but few human clinical studies of air pollution have included people with diabetes. Ultrafine particles (UFP, ≤100 nm in diameter) have been hypothesized to be an important component of particulate air pollution with regard to cardiovascular health effects.
- 16 July 2014
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 11 (1) , 31
Open AccessInhalation of ultrafine carbon particles alters heart rate and heart rate variability in people with type 2 diabetes
Diabetes may confer an increased risk for the cardiovascular health effects of particulate air pollution, but few human clinical studies of air pollution have included people with diabetes. Ultrafine particles (UFP, ≤100 nm in diameter) have been hypothesized to be an important component of particulate air pollution with regard to cardiovascular health effects.